These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 26669245)

  • 1. GPR55 - a putative "type 3" cannabinoid receptor in inflammation.
    Yang H; Zhou J; Lehmann C
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):297-302. PubMed ID: 26669245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?
    Nevalainen T; Irving AJ
    Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The putative cannabinoid receptor GPR55 promotes cancer cell proliferation.
    Hu G; Ren G; Shi Y
    Oncogene; 2011 Jan; 30(2):139-41. PubMed ID: 21057532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid Receptor-Related Orphan G Protein-Coupled Receptors.
    Irving A; Abdulrazzaq G; Chan SLF; Penman J; Harvey J; Alexander SPH
    Adv Pharmacol; 2017; 80():223-247. PubMed ID: 28826536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T; Ueno S; Obara Y; Nakahata N
    J Pharm Pharmacol; 2011 May; 63(5):636-47. PubMed ID: 21492165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cannabinoid ligands SR141716A and AM251 enhance human and mouse islet function via GPR55-independent signalling.
    Ruz-Maldonado I; Liu B; Atanes P; Pingitore A; Huang GC; Choudhary P; Persaud SJ
    Cell Mol Life Sci; 2020 Nov; 77(22):4709-4723. PubMed ID: 31925452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAMP and MRAP accessory proteins have selective effects on expression and signalling of the CB
    Glenn NAK; Finlay DB; Carruthers ER; Mountjoy KG; Walker CS; Grimsey NL
    Br J Pharmacol; 2024 Jul; 181(14):2212-2231. PubMed ID: 37085333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of GPR55, a putative cannabinoid receptor.
    Sharir H; Abood ME
    Pharmacol Ther; 2010 Jun; 126(3):301-13. PubMed ID: 20298715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The orphan receptor GPR55 is a novel cannabinoid receptor.
    Ryberg E; Larsson N; Sjögren S; Hjorth S; Hermansson NO; Leonova J; Elebring T; Nilsson K; Drmota T; Greasley PJ
    Br J Pharmacol; 2007 Dec; 152(7):1092-101. PubMed ID: 17876302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The G protein-coupled receptor 55 ligand l-α-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion.
    Kallendrusch S; Kremzow S; Nowicki M; Grabiec U; Winkelmann R; Benz A; Kraft R; Bechmann I; Dehghani F; Koch M
    Glia; 2013 Nov; 61(11):1822-31. PubMed ID: 24038453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55.
    Kargl J; Balenga N; Parzmair GP; Brown AJ; Heinemann A; Waldhoer M
    J Biol Chem; 2012 Dec; 287(53):44234-48. PubMed ID: 23161546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of GPR55 and either cannabinoid CB
    Martínez-Pinilla E; Rico AJ; Rivas-Santisteban R; Lillo J; Roda E; Navarro G; Lanciego JL; Franco R
    Brain Struct Funct; 2020 Sep; 225(7):2153-2164. PubMed ID: 32691218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation.
    Grill M; Hasenoehrl C; Kienzl M; Kargl J; Schicho R
    Histochem Cell Biol; 2019 Jan; 151(1):5-20. PubMed ID: 30196316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.
    Kapur A; Zhao P; Sharir H; Bai Y; Caron MG; Barak LS; Abood ME
    J Biol Chem; 2009 Oct; 284(43):29817-27. PubMed ID: 19723626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPR55: Current knowledge and future perspectives of a purported "Type-3" cannabinoid receptor.
    Moriconi A; Cerbara I; Maccarrone M; Topai A
    Curr Med Chem; 2010; 17(14):1411-29. PubMed ID: 20166924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum.
    Martínez-Pinilla E; Reyes-Resina I; Oñatibia-Astibia A; Zamarbide M; Ricobaraza A; Navarro G; Moreno E; Dopeso-Reyes IG; Sierra S; Rico AJ; Roda E; Lanciego JL; Franco R
    Exp Neurol; 2014 Nov; 261():44-52. PubMed ID: 24967683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mechanisms of GPR55 Receptor Functional Selectivity during Apoptosis and Proliferation Regulation in Cancer Cells.
    Akimov MG; Gretskaya NM; Dudina PV; Sherstyanykh GD; Zinchenko GN; Serova OV; Degtyaryova KO; Deyev IE; Bezuglov VV
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling.
    Balenga NA; Martínez-Pinilla E; Kargl J; Schröder R; Peinhaupt M; Platzer W; Bálint Z; Zamarbide M; Dopeso-Reyes IG; Ricobaraza A; Pérez-Ortiz JM; Kostenis E; Waldhoer M; Heinemann A; Franco R
    Br J Pharmacol; 2014 Dec; 171(23):5387-406. PubMed ID: 25048571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the natural ligand of GPR55?
    Okuno T; Yokomizo T
    J Biochem; 2011 May; 149(5):495-7. PubMed ID: 21324983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPR55: a new promising target for metabolism?
    Tudurí E; Imbernon M; Hernández-Bautista RJ; Tojo M; Fernø J; Diéguez C; Nogueiras R
    J Mol Endocrinol; 2017 Apr; 58(3):R191-R202. PubMed ID: 28196832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.